Trials / Conditions / Neuroendocrine (NE) Tumors

Neuroendocrine (NE) Tumors

11 registered clinical trials studyying Neuroendocrine (NE) Tumors — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor NCT07471425	Gustave Roussy, Cancer Campus, Grand Paris	—
Recruiting	Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine NCT06787014	Insel Gruppe AG, University Hospital Bern	—
Recruiting	Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake NCT07284589	Akiva Mintz	Phase 2
Not Yet Recruiting	Evaluation of Tolerance and Quality of Life in Patients With Neuroendocrine Tumors Treated With Oral Anti-Tumo NCT07258810	Hospices Civils de Lyon	—
Not Yet Recruiting	Imaging of Solid Tumors Using DLL3 SPECT NCT07052760	Thomas Hope	EARLY_Phase 1
Recruiting	Life Following Excision of Neuroendocrine Tumors NCT06981455	Sunnybrook Health Sciences Centre	—
Recruiting	Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms NCT07121998	Uppsala University	—
Recruiting	Use of 68Ga-DOTATOC PET/CT-enterography for Detection of the Primary Lesion in Neuroendocrine Tumors of the Sm NCT06773624	European Institute of Oncology	N/A
Completed	The Role of Intraoperative Hepatic Ultrasonography in Gastrointestinal or Pancreatic Neuroendocrine Tumor NCT06779708	Istituto Clinico Humanitas	—
Withdrawn	Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas NCT02030184	University of Maryland, Baltimore	Phase 1 / Phase 2
Terminated	Comparing 177Lu-Dotatate/Capecitabine Combination Treatment With 177Lu-Dotatate in Neuroendocrine Tumor Patien NCT07012330	Erasmus Medical Center	Phase 2